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Introduction
The ER provides an environment that facilitates the folding 
and assembly of newly synthesized secretory and transmem-
brane proteins and actively participates in the quality control 
of these proteins. By these means, correctly folded proteins are 
allowed to exit the ER to reach their fi  nal destination, whereas 
incompletely folded or misfolded molecules are retained in 
the ER. Quality control in the ER is achieved by two indepen-
dent mechanisms, the productive folding mechanism, which 
uses various molecular chaperones and folding enzymes local-
ized in the ER (ER chaperones), and the ER-associated degra-
dation (ERAD) mechanism, by which unfolded or misfolded 
proteins are retrotranslocated from the ER to the cytoplasm to 
be degraded by the ubiquitin-dependent proteasome system 
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(Gething and Sambrook, 1992; Helenius et al., 1992; Kopito, 
1997; Kaufman, 1999).
Under a variety of conditions collectively termed ER 
stress, however, quality control becomes ineffi  cient, resulting in 
the accumulation of unfolded proteins in the ER. Essentially, all 
eukaryotic cells are equipped with a system to cope with protein 
unfolding or misfolding in the ER. Interestingly, the strategy 
taken is well conserved from yeast to humans: components of 
both the productive folding and ERAD mechanisms are induced 
in response to ER stress by a transcriptional program termed the 
unfolded protein response (UPR), leading to accelerated refold-
ing and degradation of unfolded proteins, respectively (Mori, 
2000; Patil and Walter, 2001; Harding et al., 2002; Schroder 
and Kaufman, 2005). Nonetheless, an as-yet-unanswered criti-
cal question is how eukaryotic cells maintain the homeostasis of 
the ER by balancing the refolding and degradation mechanisms 
to counteract ER stress or, in other words, how proteins to be 
refolded are discriminated from those to be degraded.
Transmembrane proteins are capable of transmitting sig-
nals across the membrane, and eukaryotic cells indeed use some 
of these molecules as sensors and transducers of ER stress for the 
UPR. Among these, Ire1p/Ire-1/IRE1 is an ER membrane–bound 
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P
roteins that are unfolded or misfolded in the endo-
plasmic reticulum (ER) must be refolded or degraded 
to maintain the homeostasis of the ER. Components 
of both productive folding and ER-associated degradation 
(ERAD) mechanisms are known to be up-regulated by the 
unfolded protein response (UPR). We describe two novel 
components of mammalian ERAD, Derlin-2 and -3, which 
show weak homology to Der1p, a transmembrane pro-
tein involved in yeast ERAD. Both Derlin-2 and -3 are up-
  regulated by the UPR, and at least Derlin-2 is a target of the 
IRE1 branch of the response, which is known to up-regulate 
ER degradation enhancing α-mannosidase–like protein 
(EDEM) and EDEM2, receptor-like molecules for misfolded 
glycoprotein. Overexpression of Derlin-2 or -3 accelerated 
degradation of misfolded glycoprotein, whereas their knock-
down blocked degradation. Derlin-2 and -3 are associated 
with EDEM and p97, a cytosolic ATPase responsible for 
extraction of ERAD substrates. These ﬁ  ndings indicate that 
Derlin-2 and -3 provide the missing link between EDEM and 
p97 in the process of degrading misfolded glycoproteins.T
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endoribonuclease conserved from yeast to humans. IRE1 initiates 
unconventional (frame switch) splicing in response to ER stress 
and has the substrates yeast HAC1 mRNA and metazoan XBP1 
mRNA encoding the UPR-specifi  c transcription factors Hac1p 
and XBP1, respectively. As a result of frame-switch splicing, 
the DNA binding domain and activation domain of these sub-
strates are joined to produce a transcription factor capable of 
activating transcription effi  ciently (Kaufman et al., 2002; Mori, 
2003). A second transmembrane UPR signal transducer is pek-
1/PERK, an ER membrane–bound protein kinase conserved in 
metazoan cells. PERK activated in response to ER stress phos-
phorylates the α subunit of eukaryotic initiation factor 2, result-
ing in a general attenuation of translation (Ron, 2002). The third 
UPR transducer is ATF6, an ER membrane–bound transcription 
factor whose involvement in the UPR has to date been clarifi  ed 
for mammalian cells only. Upon ER stress, ATF6 is subjected 
to regulated intramembrane proteolysis, leading to liberation 
of the cytosolic transcription factor domain, which translocates 
into the nucleus to activate transcription (Mori, 2003). We are 
currently investigating the roles of the IRE1–XBP1 and ATF6 
pathways in the homeostasis of the ER and have proposed a 
time-dependent phase-transition model based on differential 
properties of the two signaling pathways (Yoshida et al., 2003; 
see Discussion).
Various components of ERAD have also been identifi  ed 
(Wilhovsky et al., 2000; Tsai et al., 2002). Among these, ER 
degradation enhancing α-mannosidase–like protein (EDEM) is 
a key component, as it targets misfolded glycoproteins to the 
proteasome, presumably by directly recognizing a signal that is 
present in misfolded glycoproteins, such as Man8GlcNAc2 
structure (Hosokawa et al., 2001). Transcription of EDEM is 
ER stress inducible, and its induction depends on the IRE1–
XBP1 pathway (Yoshida et al., 2003). The mammalian genome 
contains two further EDEM-like molecules, designated EDEM2 
and -3, which are also involved in the ERAD of misfolded gly-
coproteins and are ER stress inducible in a manner dependent 
on the IRE1–XBP1 pathway (Mast et al., 2004; Olivari et al., 
2005; Molinari, M., personal communication).
Recently, two groups independently identifi  ed an interest-
ing human protein that shows weak homology to yeast Der1p, a 
protein involved in yeast ERAD (Hiller et al., 1996; Knop et al., 
1996), and designated it Derlin-1 (Der1p-like protein; Fig. 1 C; 
Lilley and Ploegh, 2004; Ye et al., 2004). This protein is in-
volved in a process similar to the ERAD used by human cyto-
megalovirus to escape from the immune system (Wiertz et al., 
1996a). In this process, the US11 protein of human cytomegalo-
virus causes retrotranslocation of major histocompatibility 
complex class I heavy chain (HC) from the ER to the cytosol for 
degradation by the proteasome, in which the cytosolic ATPase 
p97 plays an essential role in extracting class I HC through the 
ER membrane (Ye et al., 2001). Given that Derlin-1 interacts 
with functional US11 but not with nonfunctional US11 and that 
it recruits p97 to the ER membrane, Derlin-1 is considered to pro-
vide the missing link between events on the lumenal side of the 
ER (recognition of class I HC by US11) and those on the cyto-
solic side (extraction catalyzed by p97; Lilley and Ploegh, 2004; 
Ye et al., 2004). The mammalian genome contains two addi-
tional Der1p-homologous proteins, designated Derlin-2 and -3. 
It was recently shown that Derlin-2 forms a complex not only 
with p97 but also with mammalian homologues of yeast Hrd1p 
and -3p, proteins involved in yeast ERAD (Wilhovsky et al., 
2000), similar to Derlin-1 (Lilley and Ploegh, 2005; Ye et al., 
2005). However, it is not known whether Derlin-2 or -3 is re-
quired for ERAD.
We demonstrate that Derlin-2 and -3, proteins regulated 
by the UPR, are functional components of ERAD for misfolded 
glycoproteins and that Derlin-2 at least is a target of the IRE1–
XBP1 pathway, similar to EDEM. We also discuss the role of 
Figure 1.  Identiﬁ   cation of Derlin-2 and -3. 
(A) The levels of CGI-101, BiP, and β-actin 
mRNA are determined by microarray analysis 
in HeLa cells treated with or without 2 μg/ml 
tunicamycin for 8 h. Fold induction was deter-
mined, with the means from six independent 
experiments presented with SDs (error bars). 
CGI-101 is identical to Derlin-2. (B) Hydropa-
thy plots of human Derlin-2 (CGI-101), -3 
(FLJ43842), and -1 are shown. Hydrophobic-
ity and hydrophilicity (expressed by positive 
and negative numbers, respectively) of the 
amino acid sequences of three human Derlins 
were obtained according to the method of 
Kyte and Doolittle (1982). Black bars mark hy-
drophobic regions that span the membrane. 
(C) Amino acid sequence alignment of human 
Derlin-2, Derlin-3 tv1, Derlin-3 tv2, Derlin-1, 
and yeast Der1p is shown. Identical amino ac-
ids are indicated by white letters in black 
boxes. Two transcriptional variants for Derlin-3 
are deposited in the data bank. Derlin-3 tv1 
lacks the 30 COOH-terminal amino acids pres-
ent in Derlin-3 tv2.T
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the mammalian UPR in distinguishing proteins to be refolded 
from those to be degraded.
Results
Derlin-2 and -3 are novel genes regulated 
by the UPR
We conducted a microarray analysis to identify novel ER stress–
inducible genes that might be involved in determining the fate of 
proteins that are unfolded or misfolded in the ER. Total RNA 
was isolated from HeLa cells that had been treated for 8 h with 
or without tunicamycin, an inhibitor of protein N-glycosylation 
known to cause ER stress (Kaufman, 1999), and the difference 
in expression levels was determined using the DNA chip cDNA 
Microarray kit human I carrying 12,814 genes. Results showed 
 300 genes that were induced more than twofold, among which 
we focused on one, CGI-101, because of its 2.9-fold induction 
by tunicamycin treatment (Fig. 1 A),the ability of hydrophobic 
stretches in its translational product to span the ER membrane 
several times (Fig. 1 B), and, most important, the weak homol-
ogy it exhibited to yeast Der1p (Fig. 1 C). Although the role of 
Der1p in ERAD remains poorly understood, these results im-
plied that CGI-101 may be a gene that connects the UPR with 
ERAD. Our database search also indicated that the human ge-
nome contains a gene somewhat similar to CGI-101 (designated 
FLJ43842; available from GenBank/EMBL/DDBJ under acces-
sion no. FLJ43842), the transcription of which we subsequently 
found to be induced in response to ER stress (see Fig. 3 B).
During the course of our subsequent analyses, proteins 
encoded by CGI-101 and FLJ43842 turned out to be identical 
to Derlin-2 and -3, respectively (see Introduction). We decided 
to follow this nomenclature hereafter and continued to inves-
tigate their functions, which remain largely uncharacterized. 
A database search indicated the presence of two variants of 
Derlin-3, probably resulting from alternative splicing. We refer 
to these short and long forms as Derlin-3 transcriptional vari-
ant (tv) 1 and 2, respectively; tv2 has 30 more amino acids at 
the COOH terminus than does tv1 (Fig. 1 C). Derlin-2 and -3 
show  75% identity, whereas that between Derlin-1 and -2 or 
Derlin-1 and -3 is  30%.
Transcript structures for Derlin-1, -2, and -3 deposited in 
the data bank are schematically shown in Fig. 2 A. Northern blot 
hybridization revealed that both a short form and a long form of 
Derlin-2 mRNA are expressed in both human and mouse and 
that in both species the short form is more abundant than the 
long form (see Figs. 2 and 3). Similarly, short and long Derlin-3 
mRNAs also exist, with the short form being more abundant in 
most human tissues; however, neither short nor long Derlin-3 
mRNA was detected in mouse embryonic fi  broblasts (MEFs; 
unpublished data). As shown in Fig. 2 (B and C), Derlin-1 
mRNA was expressed ubiquitously. Expression of Derlin-2 
mRNA also appeared ubiquitous; the apparent discrepancy in 
the level of Derlin-2 mRNA in skeletal muscle between Fig. 2 B 
(lane 6) and Fig. 2 C (lane 3) is likely attributable to a difference 
in the amount of mRNA loaded (compare the levels of β-actin 
mRNA). In contrast, expression of Derlin-3 mRNA was re-
stricted to several tissues. Both Derlin-2 and -3 mRNAs were 
detected abundantly in placenta and pancreas (Fig. 2 B), whereas 
Derlin-3 mRNA was much more abundant than Derlin-2 mRNA 
in spleen and small intestine (Fig. 2 C). The biological signifi  -
cance of these fi  ndings remains a subject for future  investigation. 
We conclude that the summed expression of Derlin-2 and -3 
mRNAs is comparable with that of Derlin-1 mRNA.
Derlin-1, -2, and probably -3 are targets 
of the IRE1–XBP1 pathway
We asked whether the transcriptional induction of Derlin-2 in 
response to ER stress depends on the IRE1–XBP1 pathway, 
similar to that observed for EDEM. Northern blot hybridiza-
tion was performed for total RNA isolated from IRE1α+/+, 
IRE1α−/−, XBP1+/+, and XBP1−/− MEFs that had been 
treated with 10 μg/ml tunicamycin. Consistent with our 
previous results (Yoshida et al., 2003), mRNA encoding  binding 
Figure 2.  Structure and tissue distribution of Derlin-2 and -3 mRNA. 
(A) Schematic structures of transcripts deposited in the data bank for hu-
man (available from GenBank/EMBL/DDBJ under accession no. NM_
024295) and mouse (NM_024207) Derlin-1, human (NM_016041) and 
mouse (NM_033562) Derlin-2, and human (NM_001002862) and mouse 
(NM_024440) Derlin-3 are shown. Black underlines indicate the respec-
tive region of cDNA probe used for Northern blot analysis. (B) A nylon 
membrane onto which  2 μg each of poly A
+ RNA prepared from eight 
human tissues was blotted after separation through gel electrophoresis (Hu-
man MTN blot) was hybridized with a DIG-labeled cDNA probe speciﬁ  c 
to human Derlin-1, Derlin-2, Derlin-3, or β-actin. Migration positions of 
molecular weight markers are indicated on the left of each panel. (C) A 
second nylon membrane onto which  1 μg each of poly A
+ RNA pre-
pared from 12 human tissues was blotted after separation through gel 
electrophoresis (Human 12-lane MTN blot) was hybridized as in B.JCB • VOLUME 172 • NUMBER 3 • 2006  386
protein (BiP), a major ER chaperone, was similarly in-
duced in response to tunicamycin treatment in both wild-type 
cells and cells lacking IRE1α or XBP1, whereas induction of 
EDEM mRNA observed in wild-type cells was abolished in 
cells lacking IRE1α or XBP1 (Fig. 3 A). We found that Derlin-2 
mRNA was induced in response to tunicamycin treatment, 
  albeit less effi  ciently than BiP mRNA (Fig. 3 A, lanes 1–5 and 
11–15), consistent with the results of microarray analysis shown 
in Fig. 1 A. We also found that Derlin-1 mRNA was ER stress 
inducible (Fig. 3 A, lanes 1–5 and 11–15). Importantly, induc-
tion of Derlin-1 or -2 observed in wild-type cells was greatly at-
tenuated in cells lacking IRE1α or XBP1 (Fig. 3 A, lanes 6–10 
and 16–20). These results indicated that Derlin-1 and -2 are 
  targets of the IRE1–XBP1 pathway of the UPR.
Derlin-3 mRNA was induced in tunicamycin-treated 
  human cells, such as 293T, and HeLa cells, and the extent of 
  induction was greater than that of Derlin-2 mRNA (Fig. 3 B). 
However, the dependence of Derlin-3 mRNA induction on the 
IRE1–XBP1 pathway could not be examined because Derlin-3 
mRNA was not detected in MEFs (unpublished data). Nonethe-
less, Derlin-3 is considered to be a target of the IRE1–XBP1 
pathway because the induction time course of Derlin-3 mRNA 
was similar to that of Derlin-2 and EDEM mRNA but clearly 
slower than that of BiP mRNA (Fig. 3 B), refl  ecting the differ-
ences in DNA binding specifi  city and activation mechanisms 
between ATF6 and XBP1 (see Discussion). These results sug-
gested that, similar to Derlin-1 and EDEM, Derlin-2 and -3 
might be components of ERAD.
Derlin-2 and -3 are ER proteins
To determine the localization of Derlin-2 and -3, their NH2-
  terminal c-myc epitope–tagged versions were transfected into 
HeLa cells. An indirect immunofl  uorescence analysis of trans-
fected cells revealed that Derlin-2 or -3 was colocalized with 
Sec61β (Fig. 4 A), a component of the translocon in the ER 
(Hartmann et al., 1994). It should be noted that overexpression 
of Derlin-1 created dot-like structures around the ER as reported 
previously (Lilley and Ploegh, 2004; Ye et al., 2004), whereas 
that of Derlin-2 or -3 did not do so, although their expression 
levels appeared comparable when detected with anti-myc 
  antibody (Fig. 4 B and see Fig. 7A).
Derlin-1 is considered to be a protein that spans the ER 
membrane four times, with both its NH2 and COOH termini 
facing the cytosol (Lilley and Ploegh, 2004; Ye et al., 2004), 
Figure 3.  Involvement of the IRE1–XBP1 pathway in the induction of 
  Derlin-1 and -2 in response to ER stress. (A) IRE1α+/+, IRE1α−/−, 
XBP1+/+, and XBP1−/− MEFs were treated with 10 μg/ml tunicamycin 
(Tm) for the indicated periods. Total RNAs were isolated and analyzed by 
Northern blot hybridization using a DIG-labeled cDNA probe speciﬁ  c to 
mouse Derlin-2, Derlin-1, EDEM, BiP, or GAPDH. Closed and open arrow-
heads indicate the migration positions of 28S ribosomal RNA (4.7 kb) and 
18S ribosomal RNA (1.9 kb), respectively. (B) 293T or HeLa cells were 
treated with 2 μg/ml tunicamycin (Tm) for the indicated periods. Total 
RNAs were analyzed as in A using a DIG-labeled cDNA probe speciﬁ  c to 
human Derlin-2, Derlin-3, EDEM, BiP, or GAPDH.
Figure 4.  Characterization of Derlin-2 and -3. (A) HeLa cells were trans-
fected with plasmid to express each Derlin tagged with the c-myc epitope 
at the respective NH2 terminus. Transfected cells were ﬁ  xed and stained 
with anti-myc and anti-Sec61β antibodies. (B) HEK293 cells were trans-
fected with plasmid to express each Derlin tagged with the c-myc epitope 
at the respective COOH terminus. Postnuclear supernatant of transfected 
cells was incubated with increasing amounts of trypsin (0, 4, 8, and 16 μg 
for lane 1, 2, 3, and 4, respectively) for 15 min at 4°C. Immunoblotting 
analysis of the samples was performed using anti-myc, anti–NH2 terminus 
of calnexin (CNX[N]), anti–COOH terminus of calnexin (CNX[C]), and 
anti-calreticulin (CRT) antibodies. (C) HEK293 cells were transfected with 
plasmid to express Derlin-2 (a) or Derlin-3 tv1 or tv2 (b) tagged with the 
c-myc epitope at either the NH2 (N) or COOH (C) terminus. 36 h later, 
transfected cells were pulse labeled with 
35S-methionine and cysteine for 
15 min and then chased for the indicated periods. Cells were lysed with 
buffer containing 1% NP-40 and subjected to immunoprecipitation analy-
sis using anti-myc antibody.DERLIN-2 AND DERLIN-3 AS COMPONENTS OF ERAD • ODA ET AL. 387
and Derlin-2 and -3 contain four hydrophobic stretches at posi-
tions similar to that of Derlin-1 (Fig. 1 B). To determine actual 
topology, Derlin-2 or -3 tagged with the c-myc epitope at the 
respective COOH terminus was transfected into human em-
bryonic kidney (HEK) 293 cells and microsomes isolated from 
transfected cells were digested with trypsin. Calnexin, which 
is a type I transmembrane protein in the ER, and calreticulin, 
which is a soluble lumenal protein, were used as controls. As 
shown in Fig. 4 B, the COOH termini of Derlin-2 and -3 were 
not protected against trypsin digestion, as was also the case for 
Derlin-1 and calnexin but not for calreticulin and the NH2 ter-
minus of calnexin, which remained intact.
Similar protease-sensitivity experiments conducted on 
Derlin-2 and -3 tagged with the c-myc epitope at the respective 
NH2 terminus gave rise to complicated results (unpublished 
data). The mode of insertion into the ER membrane may not 
have been uniform when NH2-terminally tagged Derlin-2 or -3 
was overexpressed, even though they were functional (see the 
following section). This notion was supported by the fi  nding 
from the pulse-chase analysis that NH2-terminally tagged pro-
teins were much more unstable than COOH-terminally tagged 
proteins, albeit with more abundant expression (Fig. 4 C). For-
mal conclusion that endogenous Derlin-2 and -3 are four-
transmembrane proteins in the ER with both their NH2 and 
COOH termini facing the cytosol thus requires analysis of 
their topology by raising antibodies against their NH2 and 
COOH termini.
Derlin-2 and -3 are required for ERAD
We next examined whether Derlin-2 and -3 are indeed in-
volved in ERAD using two approaches, overexpression and 
knockdown experiments. Because a previous study indicated 
that Derlin-2 does not participate in US11-mediated degrada-
tion of class I HC, a transmembrane protein in the ER (Lilley 
and Ploegh, 2004), we chose as substrate a soluble lumenal pro-
tein misfolded in the ER, the null Hong Kong (NHK) mutant 
of α1-proteinase inhibitor (α1-PI, also called α1-antitrypsin; 
Sifers et al., 1988). NHK glycosylated and misfolded in the 
lumen of the ER is recognized by EDEM for destruction by 
the proteasome in the cytosol (Hosokawa et al., 2001). Pulse-
chase experiments followed by immunoprecipitation analysis 
with antibody against α1-PI showed that NHK was degraded 
with a half-life of <3 h (Fig. 5 A, lanes 1–3). Importantly, 
overexpression of Derlin-2 or -3 accelerated the degradation of 
NHK to a half-life of  1.5 h (Fig. 5 A, lanes 4–9). This 
  acceleration was comparable with that observed with overex-
pression of EDEM (Hosokawa et al., 2001). Interestingly, both 
Derlin-2 and -3 were coimmunoprecipitated with NHK when 
cells were lysed with buffer containing 1% NP-40 (Fig. 5 A), 
and this association was lost when they were lysed with buffer 
containing 1% SDS (not depicted). Thus, as in the case 
of   Derlin-1, Derlin-2 and -3 interact with the substrate to 
be degraded.
We then asked whether overexpression of Derlin-2 and -3 
also affects degradation of nonglycoproteins misfolded in the 
ER. A previously modifi  ed NHK designated NHK(QQQ), in 
which all asparagines of three potential N-glycosylation sites 
are mutated to glutamine, was shown to degrade quite rapidly 
(Hosokawa, N., personal communication) with a half-life of 
 1 h, which is even shorter than that of NHK (Fig. 5 B, lanes 
1–3). Results showed that overexpression of Derlin-2 or -3 did 
not signifi   cantly accelerate the degradation of NHK(QQQ) 
(Fig. 5 B, lanes 4–9), indicating that Derlin-2 and -3 induced 
by the UPR assist in the degradation of misfolded glycoproteins 
but not in that of misfolded nonglycoproteins. Unexpectedly, 
both Derlin-2 and -3 coimmunoprecipitated with NHK(QQQ) 
(Fig. 5 B), indicating that the binding activity of Derlin-2 
and -3 is not simply correlated with their degradation activity. 
In this connection, we also found that EDEM located upstream 
of Derlin-2 and -3 in the degradation process (see the follow-
ing section) can bind to NHK and NHK(QQQ) with similar 
effi  ciency (unpublished data).
We then examined the effect of reducing Derlin-2 and -3 
  levels on the degradation of NHK. Double-stranded oligonu-
cleotides   corresponding to two regions each of Derlin-2 or -3 
were inserted into the mammalian expression vector pSUPER 
to produce short hairpin RNAs (shRNAs) that act as short inter-
fering RNA–like molecules in transfected cells (Brummelkamp 
et al., 2002). The knockdown effi  ciencies of these constructs 
were determined by Northern blot hybridization. As shown in 
Fig. 6 A, they effectively suppressed expression of Derlin-2 
or -3 without affecting that of other Derlins signifi  cantly. We 
Figure 5.  Effects of overexpression of Derlin-2 and -3 on degrada-
tion of NHK and NHK(QQQ). (A and B) HEK293 cells were mock-
transfected or transfected with plasmid to express Derlin-2 or Derlin-3 
tv2 tagged with the c-myc epitope at the respective NH2 terminus 
  together with plasmid to express NHK (A) or NHK(QQQ) (B). Trans-
fected cells were pulse-chased and subjected to immunoprecipitation 
analysis using anti–α1-PI antibody as in Fig. 4 C. Migration positions 
of NHK, NHK(QQQ), Derlin-2, and Derlin-3 are indicated. The radio-
activity of each NHK band was determined and expressed as relative 
to the summation of radioactivity of nine NHK bands obtained in 
each experiment. The relative radioactivity of each band was normal-
ized with the value at chase period 0 h. The means from three 
  independent experiments with SDs (error bars) are plotted against 
the chase period (bottom).JCB • VOLUME 172 • NUMBER 3 • 2006  388
therefore transfected HEK293 cells with these pSUPER de-
rivatives together with the plasmid for   expression of NHK. 
Pulse-chase experiments revealed that degradation of NHK be-
came ineffi  cient in cells with reduced levels of Derlin-2 or -3 
(Fig. 6 B), indicating that they are functional components of 
ERAD for misfolded glycoprotein. We obtained no indication 
from reporter assays that the UPR was activated in these knock-
down cells (unpublished data).
Because a reduction in the expression of Derlin-2 or -3 
alone effectively blocked the degradation of NHK, we explored 
the possibility that Derlin-2 and -3 are heterooligomerized. Re-
sults of cotransfection experiments clearly showed coimmuno-
precipitatation of HA-tagged Derlin-3 with myc-tagged Derlin-2 
and that of myc-tagged Derlin-2 with HA-tagged Derlin-3 
in  a  fairly stoichiometric manner (Fig. 6 C, lanes 6 and 8, 
  respectively). On the other hand, Derlin-1 was found to be 
poorly associated with Derlin-3 (Fig. 6 C, lanes 2 and 4), sug-
gesting that Derlin-2 and -3 may constitute a group distinct 
from Derlin-1, as suggested from the distances in the phylo-
genic tree (Lilley and Ploegh, 2004). As a reduction in the ex-
pression of Derlin-2, Derlin-3, or both had little effect on the 
synthesis and secretion of the wild-type α1-PI (Fig. 6 D), we 
concluded that they are   required for the ERAD of a soluble mis-
folded glycoprotein but not for the maturation of a correctly 
foldable protein.
Derlin-2 and -3 are associated with p97 
and EDEM
We next determined whether Derlin-2 and -3 are able to associ-
ate with known components of ERAD, such as p97, by pulse la-
beling HEK293 cells expressing COOH-terminal c-myc–tagged 
versions of Derlin-2 or -3 by transfection, followed by immuno-
precipitation. Analysis with anti-p97 antibody revealed that ev-
ery Derlin coimmunoprecipitated with p97 (Fig. 7 A, a, lanes 
7–10). In contrast, analysis with anti-myc antibody did not de-
tect signifi  cant p97 coimmunoprecipitation with any of the Der-
lins (Fig. 7 A, a, lanes 2–5). However, when FLAG-tagged p97 
was overexpressed by cotransfection, each Derlin coimmuno-
precipitated with p97 (Fig. 7 A, b, lanes 7–10) and FLAG-p97 
coimmunoprecipitated with each Derlin (Fig. 7 A, b, lanes 2–5). 
Further, coimmunoprecipitation of each Derlin with p97 was 
observed when each Derlin was tagged with the c-myc epitope 
at the respective NH2 terminus (Fig. 7 A, c, lanes 7–10). These 
results are consistent with those of previous studies demonstrat-
ing the association of Derlin-1 and -2 with p97 (Lilley and 
Ploegh, 2004, 2005; Ye et al., 2004, 2005).
We then examined whether Derlins are also able to asso-
ciate with EDEM. A similar immunoprecipitation analysis was 
performed in HEK293 cells expressing HA-tagged EDEM and 
one of the three Derlins tagged with the c-myc epitope at the re-
spective NH2 terminus by transfection. Immunoprecipitation with 
Figure 6.  Effects of knockdown of Derlin-2 and -3 on degradation 
of NHK. (A) HEK293 cells were untransfected or transfected with the 
shRNA vector pSUPER alone or pSUPER carrying a sequence correspond-
ing to a part of Derlin-2 or -3. Total RNAs were isolated 64 h after trans-
fection and analyzed by Northern blot hybridization using a DIG-labeled 
cDNA probe speciﬁ  c to human Derlin-1, Derlin-2, Derlin-3, or GAPDH. 
(B) HEK293 cells were transfected with pSUPER alone or pSUPER carry-
ing a sequence corresponding to a part of Derlin-2, Derlin-3, or both 
  together with plasmid to express NHK. Pulse-chase and subsequent 
  immunoprecipitation were performed as in Fig. 5 A 64 h after transfec-
tion. The results of three independent experiments are shown (left). 
  Normalized radioactivity of each NHK band was determined and 
is   presented as in Fig. 5 A (right). Error bars depict means ± SD.   
(C) HEK293 cells were transfected with (+) or without (−) plasmid to ex-
press Derlin-1 or -2 tagged with the c-myc epitope at the respective NH2 
terminus with (+) or without (−) plasmid to express Derlin-3 tv2 tagged 
with the HA epitope at the NH2 terminus. 36 h later, transfected cells 
were labeled with 
35S-methionine and cysteine for 2 h, lysed with buffer 
containing 1% NP-40, and subjected to immunoprecipitation analysis us-
ing anti-myc or anti-HA antibody as indicated. Migration positions of 
Derlin-1, Derlin-2, and Derlin-3 tv2 are marked. (D) HEK293 cells were 
transfected with pSUPER alone or pSUPER derivatives as in B together 
with plasmid to express the wild-type (wt) α1-PI. Pulse-chase and subse-
quent immunoprecipitation from cell lysate as well as from media were 
performed as in B. Migration positions of high-mannose and complex 
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both anti-myc and anti-HA antibodies revealed an association be-
tween EDEM and Derlin-2 and -3 (Fig. 7 B, a, lanes 2–4 and 7–9) 
but not Derlin-1 (Fig. 7 B, a, compare lanes 5 and 10 with lanes 1 
and 6, respectively), indicating a functional difference between 
Derlin-1 and a group consisting of Derlin-2 and -3. This notion 
was further confi  rmed by the next series of immunoprecipitation 
analyses. Immunoprecipitation with anti-p97 antibody revealed 
no association between EDEM and p97, even though HA-tagged 
EDEM was overexpressed in HEK293 cells by transfection (Fig. 
7 B, b, compare lane 6 with 5).   Importantly, however, immuno-
precipitation with anti-p97 antibody did reveal that there was an 
association between EDEM and p97 when Derlin-2 was overex-
pressed simultaneously with EDEM (Fig. 7 B, b, compare lane 7 
with 6). In contrast, cooverexpression of Derlin-1 did not mediate 
the association of p97 with EDEM (Fig. 7 B, b, compare lane 8 
with 6). As the level of Derlin-1 coimmunoprecipitated with p97 
was lower than that of Derlin-2 in this experiment (Fig. 7 B, b, 
compare lane 8 with 7), we increased the amount of Derlin-1–ex-
pressing plasmid DNA in the next experiment. As a result, the 
level of Derlin-1 coimmunoprecipitated with p97 became compa-
rable with that of Derlin-2 (Fig. 7 B, c, compare lane 4 with 3). 
Nevertheless, only Derlin-2 mediated the association of EDEM 
with p97 (Fig. 7 B, c, compare lane 3 with 4).
We further examined whether Derlin-2 mediates associa-
tion of NHK with p97. Immunoprecipitation analysis was per-
formed in HEK293 cells expressing NHK and Derlin-2 or -1 
tagged with the c-myc epitope at the respective NH2 terminus 
by transfection. Immunoprecipitation with anti-myc antibody 
revealed coimmunoprecipitation of NHK with Derlin-2 but 
not with Derlin-1 (Fig. 7 C, compare lanes 6 and 7 with 5). 
Immunoprecipitation with anti-p97 antibody showed no 
direct interaction between p97 and NHK (Fig. 7 C, lane 2). 
Importantly, however, p97 became associated with NHK when 
Derlin-2 was overexpressed simultaneously (Fig. 7 C, lane 3) 
and the NHK–Derlin-2 complex recovered with anti-p97 antibody 
was quantitatively similar to that recovered with anti-myc anti-
body (Fig. 7 C, lanes 3 and 6, respectively), strongly indicating 
that Derlin-2 associated with p97 was the same molecule as that 
associated with NHK. In contrast, Derlin-1 failed to   mediate the 
association of NHK with p97 (Fig. 7 C, lane 4).
These results prompted us to examine the effect of a 
  reduction in the level of Derlin-1 on the degradation of NHK. 
It was recently reported that a sequence corresponding to a part 
of Derlin-1 successfully decreased the level of Derlin-1 without 
affecting that of Derlin-2 when incorporated into the shRNA 
vector (Lilley and Ploegh, 2005). We confi  rmed this observation 
Figure 7.  Association of Derlin-2 and -3 with p97, EDEM, and NHK. (A) HEK293 cells were mock-transfected or transfected with plasmid to express each 
Derlin tagged with the c-myc epitope at the respective COOH terminus alone (a) or with plasmid to express FLAG-tagged p97 (b). HEK293 cells were also 
transfected with plasmid to express each Derlin tagged with the c-myc epitope at the respective NH2 terminus (c). 24 h later, transfected cells were labeled 
with 
35S-methionine and cysteine for 1 h, lysed with buffer containing 1% NP-40, and subjected to immunoprecipitation analysis using anti-myc or anti-p97 
antibody as indicated. Migration positions of endogenous and FLAG-tagged p97 are marked. The asterisk shows a nonspeciﬁ  c band. The short open 
  arrowhead indicates p97 coimmunoprecipitated with Derlins, whereas long open arrowheads indicate Derlins coimmunoprecipitated with p97. (B, a) 
HEK293 cells were mock-transfected or transfected with plasmid to express each Derlin tagged with the c-myc epitope at the respective NH2 terminus to-
gether with plasmid to express HA-tagged EDEM. 24 h later, transfected cells were labeled with 
35S-methionine and cysteine for 2 h, lysed, and subjected 
to immunoprecipitation analysis using anti-myc or anti-HA antibody as indicated. The migration position of EDEM is marked. The asterisk shows a nonspe-
ciﬁ  c band. The short open arrowhead indicates EDEM coimmunoprecipitated with Derlins, whereas long open arrowheads indicate Derlins coimmuno-
precipitated with EDEM. (b and c) HEK293 cells were transfected with (+) or without (−) plasmid to express HA-tagged EDEM with or without plasmid 
to express Derlin-1 or -2 tagged with the c-myc epitope at the respective NH2 terminus. Transfected cells pulse labeled and then lysed as in a were subjected 
to immunoprecipitation analysis using anti-HA or anti-p97 antibody as indicated. (c) The amount of Derlin-1 expression plasmid to transfect HEK293 cells 
was twice that of Derlin-2 expression plasmid. Migration positions of p97, EDEM, and Derlins coimmunoprecipitated with EDEM or p97 are indicated. 
(C) HEK293 cells were transfected with (+) plasmid to express NHK and with or without plasmid to express Derlin-1 or -2 tagged with the c-myc epitope 
at the respective NH2 terminus. Transfected cells were pulse labeled and then lysed as in panel a. Equal amounts of cell lysate were subjected to immuno-
precipitation analysis using anti–α1-PI, anti-p97, or anti-myc antibody as indicated. Migration positions of p97, NHK, and Derlins are indicated.JCB • VOLUME 172 • NUMBER 3 • 2006  390
by immunoblotting in our system (Fig. 8 A, lane 3). Similarly, 
our shRNA vector for Derlin-2 succeeded in decreasing the 
level of Derlin-2 without affecting that of Derlin-1 (Fig. 8 A, 
lane 4). Interestingly, knockdown of Derlin-1 had little effect on 
the degradation of NHK, whereas that of Derlin-3 reproducibly 
blocked it (Fig. 8 B). On the basis of these results, we concluded 
that Derlin-2 and -3, but not Derlin-1, function downstream of 
EDEM and are required for the degradation of NHK, a mis-
folded glycoprotein substrate of ERAD, although we cannot 
formally rule out the possibility that the residual amount of 
  Derlin-1 in Derlin-1 knocked down cells (Fig. 8 A, lane 3) is 
suffi  cient for the degradation of NHK.
Discussion
Proteins misfolded in the ER are degraded by the proteasome in 
the cytosol via a process called ERAD, in which misfolded pro-
teins are recognized inside the ER lumen, targeted to a channel, 
extracted from the ER membrane, and delivered to the protea-
some (Wilhovsky et al., 2000; Tsai et al., 2002). Misfolded 
glycoproteins are recognized by presentation of an N-linked 
oligosaccharide processing intermediates, such as Man-
8GlcNAc2 (Jakob et al., 1998), which acts as a motif that trig-
gers binding to EDEM (Hosokawa et al., 2001). In this way, 
glycoproteins that are unable to fold properly are transferred 
from calnexin, a glucoprotein-specifi  c molecular chaperone, to 
EDEM (Molinari et al., 2003; Oda et al., 2003). Subsequently, 
the cytosolic multifunctional protein p97 acts to extract the gly-
coprotein from the ER membrane (Dai and Li, 2001; Ye et al., 
2001; Braun et al., 2002; Kobayashi et al., 2002; Meyer et al., 
2002). However, the events that link these two steps have 
 remained  undefi  ned.
The recent identifi  cation of Derlin-1 has brought new in-
sights into the molecular mechanism of the US11-mediated ret-
rotranslocation of class I HC, providing a missing link between 
events in the ER and those in the cytosol (Lilley and Ploegh, 
2004; Ye et al., 2004). Further, the fi  ndings that Derlin-1 binds 
to misfolded and ubiquitinated proteins and that RNA interfer-
ence of Derlin-1 in Caenorhabditis elegans evokes ER stress 
suggest a more generalized role of Derlin-1 in ERAD (Ye et al., 
2004). Recent studies demonstrated that Derlin-1 is associated 
with ubiquitin ligases such as HRD1 and gp78 via binding to 
p97 and vasolin-containing protein (VCP)–interacting mem-
brane protein and that Derlin-2 also forms such a multiprotein 
complex, consisting of p97, VCP-interacting membrane protein, 
HRD1, and HRD3/SEL1L (Lilley and Ploegh, 2005; Ye et al., 
2005). However, it remains to be determined whether Derlin-2 
is required for ERAD.
We show that the properties of Derlin-2 and -3 are exactly 
those expected for proteins able to provide the missing link be-
tween EDEM and p97 in the process of degrading glycoproteins 
misfolded in the ER. Derlin-2 and -3 are transmembrane pro-
teins that span the ER membrane multiple times (Figs. 1 and 4) 
and are required for the ERAD of misfolded glycoprotein (Figs. 
5 and 6). They are associated with the degradation substrate, 
p97, and EDEM (Figs. 5 and 7). p97 and EDEM form a com-
plex only in the presence of Derlin-2 (Fig. 7 B), and Derlin-2 
mediates the association of p97 with the degradation substrate 
(Fig. 7 C). In contrast, Derlin-1 does not mediate the association 
of p97 with either EDEM or the degradation substrate (Fig. 7, B 
and C). This specifi  city might be attributable to differences in 
amino acid sequences between Derlin-1 and -2 (Fig. 1 C) or, as 
Derlin-1 and -2 or -3 appear to be associated with different cel-
lular proteins (Fig. 7 A), to differences in accessory proteins.
Interestingly, MEFs express only Derlin-2 mRNA, 
whereas human cells express both Derlin-2 and -3 mRNAs 
(Figs. 2 and 3 and not depicted). In addition, Derlin-2 and -3 
mRNAs are distributed differently in various human tissues 
(Fig. 2). The fi  nding that the knockdown of Derlin-2 or -3 alone 
effectively blocked the degradation of a misfolded glycoprotein 
(Fig. 6 B) suggested that they may form heterooligomers to 
function when expressed simultaneously, and this was indeed 
shown to be the case (Fig. 6 C). Similarly, they may form ho-
mooligomers when expressed singularly. It is of great interest 
whether Derlin-2 and -3 themselves can form a channel through 
which misfolded glycoproteins move from the ER   lumen to the 
cytosol, as has been proposed for Derlin-1 (Lilley and Ploegh, 
2004; Ye et al., 2004). We are also aware of a recent study 
showing that the proteasome binds directly to Sec61   (Kalies 
et al., 2005), supporting the idea that misfolded proteins are 
Figure 8.  Effects of knockdown of Derlin-1 on degradation of NHK. (A) HEK293 cells were untransfected or transfected with pSUPER alone or pSUPER 
carrying a sequence corresponding to a part of Derlin-1, -2, or -3. 64 h later, transfected cells were subjected to immunoblotting analysis using antibody 
against Derlin-1, Derlin-2, or GAPDH. (B) HEK293 cells were transfected with pSUPER alone or pSUPER carrying a sequence corresponding to a part of 
Derlin-1 or -3 together with plasmid to express NHK. 64 h later, transfected cells were pulse-chased, lysed, and subjected to immunoprecipitation as in 
Fig. 6 B (left). The results of three independent experiments are shown. Normalized radioactivity of each NHK band was also determined and is presented 
as in Fig. 5 A (right). Error bars depict mean ± SD.DERLIN-2 AND DERLIN-3 AS COMPONENTS OF ERAD • ODA ET AL. 391
  retrotranslocated from the ER to the cytosol through the trans-
locon as originally proposed (Wiertz et al., 1996b). Thus, it ap-
pears that we are a far way from any conclusive determination 
on this issue.
The UPR consists of transcriptional control only in yeast, 
and the Ire1p-mediated program covers transcriptional induc-
tion of not only ER chaperones but also components of ERAD 
in response to ER stress (Kaufman, 1999; Mori, 2000; Patil and 
Walter, 2001). On this basis, the UPR plays little role in deter-
mining the fate of unfolded or misfolded proteins in yeast ER. 
The activated refolding system and degradation system may 
deal with unfolded proteins in a competitive manner. In con-
trast, metazoan cells have developed the ability to attenuate 
translation via activation by PERK in response to ER stress, 
thereby decreasing the burden on the ER (Ron, 2002). Mammals 
have further evolved two signaling pathways, namely the ATF6 
and IRE1–XBP1 pathways, for transcriptional induction of ER 
chaperones and components of ERAD in response to ER stress 
(Mori, 2003). The transcription factor ATF6 is activated by a 
posttranslational mechanism, whereas the transcription factor 
XBP1 is activated by a posttranscriptional mechanism, causing 
the active form of ATF6 to be detected in cell extracts earlier 
than the active form of XBP1. In addition, XBP1 has broader 
target specifi  city than ATF6. Thus, the transcription of genes 
unaffected by the active form of ATF6 can be later induced by 
the active form of XBP1, allowing a time-dependent decision 
(Yoshida et al., 2001).
Accumulating evidence indicates that the ATF6 pathway 
mainly controls the expression of ER chaperones, whereas the 
IRE1–XBP1 pathway regulates the expression of not only ER 
chaperones but also components of ERAD such as EDEM, 
EDEM2, and HRD1 (Kaneko et al., 2002; Okada et al., 2002; 
Lee et al., 2003; Yoshida et al., 2003; Olivari et al., 2005). Our 
present analysis adds Derlin-1, -2, and probably -3 to the list of 
targets of the IRE1–XBP1 pathway (Fig. 3 and Table I). We 
have also found that the misfolded glycoprotein NHK was 
  degraded more slowly in IRE1α−/− cells than in IRE1α+/+ 
cells (Yoshida et al., 2003), whereas the misfolded nonglyco-
protein NHK(QQQ) was degraded at similar rates in both cell 
types (unpublished data). These results strongly support our 
time-dependent phase-transition model for determining the fate 
of proteins that are unfolded or misfolded in the mammalian 
ER, at least as far as glycoproteins are concerned, in which the 
ATF6-mediated unidirectional phase (refolding only) is shifted 
to the XBP1-mediated bidirectional phase (refolding plus deg-
radation) depending on the quality, quantity, or both of unfolded 
or misfolded proteins in the ER (Yoshida et al., 2003). The 
availability of multiple pathways for transcriptional control 
confers diversity for mammalian cells to adjust to the accumula-
tion of unfolded proteins in the ER.
Materials and methods
Microarray analysis
Total RNA was isolated from HeLa cells that had been untreated or treated 
with 2 μg/ml tunicamycin for 8 h by the acid guanidium/phenol/chloro-
form method using ISOGEN (Nippon Gene) and was further puriﬁ  ed using 
RNeasy Midi (QIAGEN). 20-μg aliquots of total RNA from tunicamycin-
treated and untreated cells were labeled with cyanine 3– and cyanine 
5–2′-deoxycytidine 5′-triphosphate, respectively, using a Direct-Label 
cDNA synthesis kit (Agilent Technologies) in three of six independent ana-
lyses. In the other three analyses, the labeling dyes were swapped to avoid 
false induction resulting from biased labeling. Labeled cDNAs were mixed 
and hybridized with a human 1 cDNA microarray kit (Agilent Technol-
ogies), on which 12,814 human cDNA clones were spotted. Fluorescence 
intensities of cyanine 3 and 5 were determined for each spot using a Ge-
nePix 4000B and GenePix Pro 4.0 software (Axon Instruments, Inc.) and 
normalized so that the sum of cyanine 3 intensities of all spots was equal 
to that of cyanine 5 intensities of all spots. Fold induction caused by tunica-
mycin treatment was deﬁ  ned as the ratio of normalized intensity for treated 
cells to that for untreated cells.
cDNA cloning and plasmid construction
Recombinant DNA techniques were performed according to standard pro-
cedures (Sambrook et al., 1989). Human Derlin-1 and -2 partial cDNAs 
containing the respective complete open reading frame were obtained by 
reverse transcription–coupled polymerase chain reaction using total RNA 
isolated from HEK293T cells and the following primers: 5′-A  T  C  T  T  G  G  C  T  A  C-
C  T  G  T  G  G  G  T  C  G  A  A  G  A  T  G  T  C  G  -3′ and 5′-A  A  C  G  C  A  G  T  T  G  T  T  A  A  G  T  G  C  A  C  C-
C  A  G  C  A  C  T  G  G  -3′ for Derlin-1 and 5′-G  G  A  A  G  A  T  G  G  C  G  T  A  C  C  A  G  A  G  C  -3′ 
and 5′-G  C  T  G  C  T  T  T  A  A  C  C  T  C  C  A  A  G  C  C  -3′ for Derlin-2. Mouse Derlin-2  partial 
cDNA containing the complete open reading frame was obtained similarly 
using total RNA isolated from MEF and the primers 5′-G  G  A  A  A  G  A  T  G  G-
C  G  T  A  C  C  A  G  A  G  C  -3′ and 5′-T  C  T  C  G  T  A  A  T  T  G  G  C  A  C  C  G  C  T  G  -3′. cDNAs for 
human Derlin-3, mouse Derlin-1, and mouse Derlin-3 were purchased as 
IMAGE cDNA clones (IMAGE ID 30338943, 2655640, and 3582647, 
respectively) from Open Biosystems. pCMV-Myc (CLONTECH Laboratories, 
Inc.) and pcDNA3.1/Myc-His(+)A (Invitrogen) were used to express each 
Derlin tagged with the c-myc epitope at the NH2 and COOH terminus, 
respectively. pCMV-SPORT2-EDEM-HA to express HA-tagged EDEM as well 
as pREP9–α1-PI and pREP9-NHK to express the wild-type α1-PI and its NHK 
mutant were described previously (Hosokawa et al., 2001; Yoshida et al., 
2003). Plasmids to express NHK(QQQ) and FLAG-tagged p97 were gifts 
Table I. List of mammalian ERAD components regulated by the IRE1–XBP1 pathway
Component
Induction
upon ER stress
Dependence on the
IRE1–XBP1 pathway Reference
ER α1, 2-mannosidase I no — Hosokawa et al., 2001
EDEM yes yes Hosokawa et al., 2001; Yoshida et al., 2003
EDEM2 yes yes Olivari et al., 2005
EDEM3 yes yes Molinari, M., personal communication
HRD1 yes yes Kaneko et al., 2002
HRD3/SEL1 yes no Kaneko and Nomura, 2003
Derlin-1 yes yes Lilley and Ploegh, 2005; this study
Derlin-2 yes yes Lilley and Ploegh, 2005; this study
Derlin-3 yes yes
a this study
aPresumed but not directly demonstrated (Fig. 3).JCB • VOLUME 172 • NUMBER 3 • 2006  392
of N. Hosokawa (Kyoto University, Kyoto, Japan) and M. Tagaya (Tokyo 
University of Pharmacy and Life Science, Tokyo, Japan) respectively.
Cell culture and transfection
HEK293, HEK293T, and HeLa cells, as well as IRE1α+/+, IRE1α−/− 
(Lee et al., 2002), XBP1+/+, and XBP1−/− (gifts of L. Glimcher, Har-
vard University, Cambridge, MA) MEFs, were cultured at 37°C in a 
  humidiﬁ  ed 5% CO2/95% air atmosphere in Dulbecco’s modiﬁ  ed Eagle’s 
medium   (glucose at 4.5 g/liter) supplemented with 10% fetal bovine 
  serum, 2 mM glutamine, and antibiotics (100 U/ml penicillin and 100 
μg/ml streptomycin). Transfection was performed using Fugene6 (Roche) 
and   Lipofectamine 2000 (Invitrogen) transfection reagents according to 
the manufacturers’ instructions.
Northern blot hybridization
Total RNA was isolated from cultured cells using ISOGEN. 5 μg each of 
  total RNA were subjected to 1.2% agarose gel electrophoresis containing 
2.2 M formaldehyde and transferred to a nylon membrane. RNA isolated 
from human tissues was separated by electrophoresis and blotted on a 
membrane (Human MTN blot and Human 12-lane MTN blot; CLONTECH 
Laboratories, Inc.). Digoxigenin (DIG)-labeled cDNA probes were pre-
pared using polymerase chain reaction according to the manufacturer’s 
  instruction (Roche) and hybridized with RNA blotted on a membrane in an 
ultrasensitive hybridization buffer (ULTRAhyb; Ambion). Subsequent reac-
tion with anti-DIG antibody (Roche) and treatment with chemiluminescent 
detection reagent CDP-star (GE Healthcare) were performed according to 
the manufacturers’ speciﬁ  cation. Chemiluminescence was visualized using 
an LAS-1000plus LuminoImage analyzer (FujiFilm).
Indirect immunoﬂ  uorescence
HeLa cells grown directly on slide glass in a 24-well plate were transfected 
with plasmid to express each Derlin tagged with the c-myc epitope at the 
respective NH2 terminus. 36 h later, cells were ﬁ  xed with 4% formaldehyde 
at room temperature for 10 min, permeabilized with 0.2% Triton-X 100 
in PBS, reacted with mouse anti-myc antibody (Santa Cruz Biotechnology, 
Inc.) and rabbit anti-Sec61β antibody (Upstate Biotechnology) for 1 h, 
and incubated with FITC-conjugated anti–rabbit IgG antibody (MP Bio-
medicals) or rhodamine-conjugated anti–mouse IgG antibody (Cappel). 
Fluorescence was visualized using a laser-scanning microscope (Eclipse 
E800; Nikon).
Protection assay and immunoblotting
HEK293 cells were transfected with plasmid to express each Derlin 
tagged with the c-myc epitope at the respective COOH terminus. Trans-
fected cells were homogenized in sucrose buffer (50 mM Tris-Cl, pH 8.0, 
containing 0.32 M sucrose, 1 mM dithiothreitol, and 1 mM EDTA). Post-
nuclear supernatant obtained after 1,000 g centrifugation was treated 
with various concentrations of trypsin at 4°C for 15 min. Digestion was 
terminated by adding SDS sample buffer and boiling for 15 min. Immuno-
blotting was performed using antibodies against myc (Santa Cruz Biotech-
nology, Inc.), calnexin (StressGen Biotechnologies), and calreticulin 
(Afﬁ  nity BioReagents, Inc.) and by reaction with Western blotting luminol 
reagent (Santa Cruz Biotechnology, Inc.). Chemiluminescence was visual-
ized using a LAS-1000plus LuminoImage analyzer. Antibodies against 
Derlin-1 and -2 were purchased from MBL International Corporation, and 
anti–glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody was 
obtained from Trevigen.
Metabolic labeling and immunoprecipitation
Cells were incubated for 30 min in methionine- and cysteine-free Dulbecco’s 
modiﬁ  ed Eagle’s medium (Invitrogen) supplemented with 2 mM glutamine 
and 10% dialyzed fetal bovine serum. Cells were then pulse labeled with 
4.1 Mbq/dish EXPRE
35S
35S protein labeling mixture (NEN Life Science 
Products) and chased in fresh complete medium. Cells were lysed in buffer 
A (50 mM Tris-Cl, pH 8.0, containing 1% NP-40, 150 mM NaCl, and 
protease inhibitors). Immunoprecipitation was performed with anti–α1-PI 
antibody (DakoCytomation), anti-myc antibody (Santa Cruz Biotechnology, 
Inc.), anti-HA antibody (Santa Cruz Biotechnology, Inc.), or anti-VCP anti-
body (Afﬁ  nity BioReagents, Inc.) and protein A– or G–coupled Sepharose 
beads (GE Healthcare). Beads were washed in high ionic buffer (50 mM 
Tris-Cl, pH 8.0, containing 1% NP-40 and 150 mM NaCl) twice, washed 
in low ionic buffer (10 mM Tris-Cl buffer, pH 7.4), and boiled in Laemmli’s 
sample buffer. Immunoprecipitates were subjected to SDS-PAGE, and radio-
active bands were analyzed using a FLA-3000G FluoroImage analyzer 
(FujiFilm). Cells were also lysed in buffer A plus 1% SDS, boiled for 5 
min, diluted with four volumes of buffer A, and centrifuged at 13,000 g. 
The resulting supernatant was used for subsequent immunoprecipitation.
Knockdown of Derlin-2 and -3
Double-stranded oligonucleotides corresponding to ﬁ   ve regions each of 
human Derlin-2 and -3 were inserted into the shRNA expression vector 
pSUPER (OligoEngine) between the BglII and HindIII sites. HEK293 cells 
were transfected with 4 μg of pSUPER or pSUPER derivatives for Northern 
blot   hybridization. Two regions each were found to decrease Derlin-2 and 
-3 mRNA levels effectively, i.e., sh-Derlin-2 (1), 441–459; sh-Derlin-2 (2), 
737–755; sh-Derlin-3 (1), 2160–2178; and sh-Derlin-3 (2), 3088–3106, 
where A of the initiation codon ATG is set as 1. The sequence to knockdown 
Derlin-1 was obtained from a recent study (Lilley and Ploegh, 2005).
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